PAA 3.13% 16.5¢ pharmaust limited

Ann: Key Licence Provided by NewSouth Innovations, page-6

  1. 613 Posts.
    lightbulb Created with Sketch. 180
    re: Ann: Key Licence Provided by NewSouth Inn... My understanding is that's its a new patent and a new licence for treating cancer with their drug plus traditional chemo drugs.

    Second two paragraphs state:

    The discovery relates to the significant enhancement of the anti-cancer activity of certain well-established mainstream approved cancer drugs without simultaneously enhancing the associated side-effect profile occurring through the killing of normal-dividing cells; a factor that often limits the therapeutic value and utility of chemotherapy.

    PharmAust is proceeding to undertake further work on this discovery as part of its development of its key anti-cancer product, PPL-1.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.